Back
Esperion Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
ESPR
Esperion Therapeutics, Inc.
Last Price:
$3.97
Seasonality Move:
30.02%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing slight selling pressure.
Esperion Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.84 | Buy |
| 20-day SMA: | 3.84 | Buy |
| 50-day SMA: | 3.26 | Buy |
| 200-day SMA: | 2 | Buy |
| 8-day EMA: | 3.88 | Buy |
| 20-day EMA: | 3.74 | Buy |
| 50-day EMA: | 3.36 | Buy |
| 200-day EMA: | 2.45 | Buy |
Esperion Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 59.41 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.37 - 4.03) | Buy |
| Bollinger Bands (100): | (2.24 - 3.46) | Buy |
Esperion Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics, Inc. Stock
Is Esperion Therapeutics, Inc. Stock a Buy?
-
Esperion Therapeutics, Inc. share price is 3.95 while ESPR 8-day simple moving average is 3.84, which is a Buy signal.
-
The stock price of ESPR is 3.95 while Esperion Therapeutics, Inc. 20-day SMA is 3.84, which makes it a Buy.
-
Esperion Therapeutics, Inc. 50-day simple moving average is 3.26 while ESPR share price is 3.95, making it a Buy technically.
-
ESPR stock price is 3.95 and Esperion Therapeutics, Inc. 200-day simple moving average is 2.00, creating a Buy signal.
ESPR Technical Analysis vs Fundamental Analysis
Buy
52
Esperion Therapeutics, Inc. (ESPR)
is a Buy
Is Esperion Therapeutics, Inc. a Buy or a Sell?
-
Esperion Therapeutics, Inc. stock is rated a BuyThe current Esperion Therapeutics, Inc. [ESPR] share price is $3.95. The Score for ESPR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Esperion Therapeutics, Inc. Stock Info
Market Cap:
936.4M
Price in USD:
3.95
Share Volume:
2.6M
Esperion Therapeutics, Inc. 52-Week Range
52-Week High:
4.13
52-Week Low:
0.69
Buy
52
Esperion Therapeutics, Inc. (ESPR)
is a Buy
Esperion Therapeutics, Inc. Share Price Forecast
-
What is the Esperion Therapeutics, Inc. stock price today?The Esperion Therapeutics, Inc. stock price is 3.95 USD today.
-
Will ESPR stock go up or go down?Esperion Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Esperion Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics, Inc. is not overvalued.
Is Esperion Therapeutics, Inc. Stock a Buy?
-
Esperion Therapeutics, Inc. share price is 3.95 while ESPR 8-day exponential moving average is 3.88, which is a Buy signal.
-
The stock price of ESPR is 3.95 while Esperion Therapeutics, Inc. 20-day EMA is 3.74, which makes it a Buy.
-
Esperion Therapeutics, Inc. 50-day exponential moving average is 3.36 while ESPR share price is 3.95, making it a Buy technically.
-
ESPR stock price is 3.95 and Esperion Therapeutics, Inc. 200-day simple moving average is 2.45, creating a Buy signal.
Fundamental Analysis of Esperion Therapeutics, Inc.
Is Esperion Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.10 per share.
Technical Analysis of Esperion Therapeutics, Inc.
Should I short Esperion Therapeutics, Inc. stock?
-
ESPR Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Esperion Therapeutics, Inc. is a Buy
-
Esperion Therapeutics, Inc. Relative Strength Index (RSI) is 59.41, which suggest Esperion Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Esperion Therapeutics, Inc. is (3.37 - 4.03), which suggest Esperion Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Esperion Therapeutics, Inc. is (2.24 - 3.46), which suggest Esperion Therapeutics, Inc. is a Buy
* Esperion Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.